Aurobindo Pharma gets USFDA nod for generic of Revatio drug

Aurobindo Pharma gets USFDA nod for generic of Revatio drug

The drug is used to treat pulmonary arterial hypertension and improve exercise capacity in adults

FPJ Web DeskUpdated: Thursday, December 29, 2022, 11:16 AM IST
article-image
Image credit: Wikipedia (Representative)

Aurobindo Pharma Ltd has received USFDA (US Food and Drug Administration) approval to market sildenafil citrate oral suspension in a 10 mg per mL strength, according to an update on the drug regulator's website.

The drug is a generic version of Viatris Inc's Revatio oral suspension.

It is used to treat pulmonary arterial hypertension and improve exercise capacity in adults.

RECENT STORIES

Adani Defence Investment Plan, Big Push To India’s Security As Group Plans ₹1.8 Lakh Crore...

Adani Defence Investment Plan, Big Push To India’s Security As Group Plans ₹1.8 Lakh Crore...

Year-Ender 2025: Indian Equities Bounce Back After Correction, Earnings & Rate Cuts To Shape 2026

Year-Ender 2025: Indian Equities Bounce Back After Correction, Earnings & Rate Cuts To Shape 2026

Bajaj Finance Drags Markets Lower This Week, Here's What Pulled Down Top Stocks?

Bajaj Finance Drags Markets Lower This Week, Here's What Pulled Down Top Stocks?

Foreign Investors Pull Out At Record Pace, Here’s What Triggered ₹1.6 Lakh Crore Exit From...

Foreign Investors Pull Out At Record Pace, Here’s What Triggered ₹1.6 Lakh Crore Exit From...

Macro Data, FPI Trading To Steer Markets This Week, Analysts See Range-Bound Moves

Macro Data, FPI Trading To Steer Markets This Week, Analysts See Range-Bound Moves